Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence for Efficacy of Treatment With the Anti-PD-1 Mab Nivolumab in Radiation and Multichemorefractory Advanced Penile Squamous Cell Carcinoma.

Journal of immunotherapy (Hagerstown, Md. : 1997) - 1 Jan 2000

Trafalis Dimitrios T, Alifieris Constantinos E, Kalantzis Anastasios, Verigos Kosmas E, Vergadis Chrysovalantis, Sauvage Sébastien

Abstract excerpt

Penile squamous cell carcinoma (PeSCC) is a rare tumor and advanced PeSCC is associated with poor survival due to the aggressiveness of the disease and lack of effective systemic therapies. We describe for the first time a case with advanced chemoradiation refractory PeSCC who had documented response to active immunotherapy with the immune checkpoint inhibitor, anti-programmed death-1 monoclonal antibody...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemoradiotherapy
Share to Cyclin-Dependent Kinase Inhibitor p16

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphocytes, Tumor-Infiltrating

Share to Nivolumab

Share to Penile Neoplasms

Share to Programmed Cell Death 1 Receptor

Share to T-Lymphocytes, Cytotoxic

Share to Tumor Burden

Source

Identifiers

PMID: 29642086
DOI: 10.1097/CJI.0000000000000221

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence for Efficacy of Treatment With the Anti-PD-1 Mab Nivolumab in Radiation and Multichemorefractory Advanced Penile Squamous Cell Carcinoma.PMID 29642086Read ↗

The Immune Microenvironment in Penile Squamous Cell Carcinoma: Distinctions Between HPV-Driven and HPV-Independent PathwaysSemantic proximity Read ↗

Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.Semantic proximity Read ↗

Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinomaSemantic proximity Read ↗

Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study.Semantic proximity Read ↗

Nivolumab for unresectable cutaneous epithelial malignancies: An open-label, single-arm, multi-centre, phase II trial (NMSC-PD1)Semantic proximity Read ↗

Case report of penile squamous cell carcinoma continuous treatment with BRCA2 mutation.Semantic proximity Read ↗

The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy.Semantic proximity Read ↗

A Prospective Study Investigating the Efficacy and Toxicity of Definitive ChemoRadadiation and ImmunOtherapy (CRIO) in Locally and/or Regionally Advanced Cutaneous Squamous Cell Carcinoma.Semantic proximity Read ↗

Sintilimab-Induced Diabetic Ketoacidosis in A Patient with Radiation and Multichemorefractory Penile Cancer: A Case Report and Literature ReviewSemantic proximity Read ↗

Expression profile and in vitro blockade of programmed death-1 in human papillomavirus-negative head and neck squamous cell carcinoma.Semantic proximity Read ↗

Chemotherapy after progression on nivolumab is essential for responders with genetic alterations of driver gene: Review of two recurrent/metastatic oral squamous cell carcinoma patients.Semantic proximity Read ↗

Establishment and characterization of a penile cancer cell line, penl1, with a deleterious TP53 mutation as a paradigm of HPV-negative penile carcinogenesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.